Related Experiment Video
Updated: Oct 17, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair
Chen-Hui Cao1, Han Ling1, Kai Han1,2
1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Abstract:
Colorectal carcinoma (CRC) is the second most deadly cancer worldwide. Therapies that take advantage of DNA repair defects have been explored in various tumors but not yet systematically in CRC. Here, we found that Diphosphoinositol Pentakisphosphate Kinase 2 (PPIP5K2), an inositol pyrophosphate kinase, was highly expressed in CRC and associated with a poor prognosis of CRC patients. In vitro and in vivo functional studies demonstrated that PPIP5K2 could promote the proliferation and migration ability of CRC cells independent of its inositol pyrophosphate kinase activity. Mechanically, S1006 dephosphorylation of PPIP5K2 could accelerate its dissociation with 14-3-3 in the cytoplasm, resulting in more nuclear distribution. Moreover, DNA damage treatments such as doxorubicin (DOX) or irradiation (IR) could induce nuclear translocation of PPIP5K2, which subsequently promoted homologous recombination (HR) repair by binding and recruiting RPA70 to the DNA damage site as a novel scaffold protein. Importantly, we verified that S1006 dephosphorylation of PPIP5K2 could significantly enhance the DNA repair ability of CRC cells through a series of DNA repair phenotype assays. In conclusion, PPIP5K2 is critical for enhancing the survival of CRC cells via facilitating DNA HR repair. Our findings revealed an unrecognized biological function and mechanism model of PPIP5K2 dependent on S1006 phosphorylation and provided a potential therapeutic target for CRC patients.
Insights
Diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) promotes colorectal cancer (CRC) survival by enhancing DNA repair. Targeting PPIP5K2, particularly its S1006 dephosphorylation, offers a potential therapeutic strategy for CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Colorectal carcinoma (CRC) is a leading cause of cancer mortality globally.
- Targeting DNA repair defects is a promising therapeutic avenue in oncology, yet underexplored in CRC.
- The role of Diphosphoinositol Pentakisphosphate Kinase 2 (PPIP5K2) in CRC remains largely unknown.
Purpose of the Study:
- To investigate the role and mechanism of PPIP5K2 in colorectal cancer progression.
- To determine the association between PPIP5K2 expression and patient prognosis.
- To explore PPIP5K2 as a potential therapeutic target in CRC.
Main Methods:
- In vitro and in vivo functional assays to assess PPIP5K2's impact on CRC cell proliferation and migration.
- Analysis of PPIP5K2 subcellular localization and its regulation by S1006 phosphorylation.
- Investigation of PPIP5K2's role in DNA damage response, specifically homologous recombination (HR) repair, using DNA damage treatments (doxorubicin, irradiation).
- Assessment of PPIP5K2's interaction with DNA repair proteins like RPA70.
Main Results:
- PPIP5K2 is highly expressed in CRC and correlates with poor patient prognosis.
- PPIP5K2 enhances CRC cell proliferation and migration independently of its kinase activity.
- S1006 dephosphorylation of PPIP5K2 promotes its nuclear translocation.
- Nuclear PPIP5K2 acts as a scaffold protein, facilitating HR repair by recruiting RPA70 to DNA damage sites.
- DNA damage induces PPIP5K2 nuclear translocation and enhances DNA repair capacity.
Conclusions:
- PPIP5K2 plays a critical role in enhancing colorectal cancer cell survival through the facilitation of DNA homologous recombination repair.
- PPIP5K2's function is modulated by S1006 phosphorylation, influencing its nuclear localization and DNA repair activity.
- PPIP5K2 represents a novel therapeutic target for colorectal cancer, with its S1006 phosphorylation status being a key factor.
Related Concept Videos
Abnormal Proliferation
Homologous Recombination
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Long-patch Base Excision Repair
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

